Defect in zinc supply mechanism affects pathology of intractable pulmonary diseases

December 29, 2017, Kumamoto University
In normal lungs, the transporter ZIP2 (WT-ZIP2: the bullet train, or "Shinkansen", on the left side of the figure) controls zinc transport and delivers zinc to lung epithelial cells. For this regulatory mechanism, it is important that the expression/function of CFTR (the tree in the figure) is normal and the expression/function of ENaC (tobacco at the bottom right of the figure) are low. On the other hand, in lungs with obstructive pulmonary disease, the expression/function of CFTR are low and ENaC expression/function is excessive. Credit: Associate Professor Tsuyoshi Syuto

Obstructive pulmonary disease is a collective term for refractory respiratory diseases with chronic airway inflammation and excessive mucus retention that are accompanied by airway obstruction. They include chronic obstructive pulmonary disease (COPD) that presents with chronic bronchitis or pulmonary emphysema, and cystic fibrosis (CF), an intractable hereditary disease characterized by mucus retention and chronic bacterial infection.

A main cause of COPD is cigarette smoke, and the global mortality rate for the now places it in third place. In Japan, the number of patients with COPD over 40 years old is estimated to be about 5.3 million people, making it a familiar disease with a high mortality rate. The onset and progression of the disease is caused by transporter proteins that allow ions to permeate ion channels into cells. COPD is thought to involve the overactivation of the epithelial sodium ion (Na+) channel (ENaC). CF, on the other hand, is a frequently occurring genetic disease in Western countries that is caused by genetic mutation of a chloride ion (Cl-) channel called the transmembrane conductance regulator (CFTR).

Excessive production of mucus-producing genes (such as MUC5AC) in the lungs is known to be important in the development of diseases such as COPD and CF. However, it was not clear why excessive production of these mucus genes occurs in these pulmonary diseases, particularly since they have such different causes, i.e., tobacco and heredity.

Pre-mRNA undergoes mRNA splicing which "cuts out" the information necessary for protein synthesis. In obstructive pulmonary diseases (right side of figure) abnormalities occur during mRNA splicing and cause abnormal (hyper-) mucus secretion. Credit: Associate Professor Tsuyoshi Syuto

In breakthrough work, researchers of Kumamoto University, Japan have now made it clear that abnormalities of the ENaC and CFTR reduce the body's ability to deliver zinc ions (Zn2+) to lung epithelial cells. (One of the zinc ion transporting factors, ZIP2, is an important mechanism for mRNA splicing to function correctly.) In addition, the researchers also revealed that COPD and CF lung epithelial cells have abnormalities in mRNA ligation, which, as a result, causes overproduction of mucous genes. In other words, the diseases developed due to an overproduction of mucus was, in turn, was caused by an insufficient zinc supply to lung epithelial cells.

In general, zinc is a very important element, not only for the lung but also for entire body. Until now, the importance of zinc in the was only understood from a nutritional aspect. The researchers believe that this discovery is the first in the world that clarifies how zinc is involved in the onset of pulmonary diseases, as well as its effects on the regulation of mRNA, one of the molecule responsible for life as we know it.

These results prove that there is abnormality in the zinc transport mechanism itself in obstructive pulmonary diseases. It also suggests that treatment for these diseases cannot be performed merely with supplements. A therapeutic approach that takes the transport mechanisms into consideration is also necessary.

Explore further: New mouse model helps in search for better COPD and CF treatments

More information: Shunsuke Kamei et al, Zinc Deficiency via a Splice Switch in Zinc Importer ZIP2/SLC39A2 Causes Cystic Fibrosis-Associated MUC5AC Hypersecretion in Airway Epithelial Cells, EBioMedicine (2017). DOI: 10.1016/j.ebiom.2017.12.025

Related Stories

New mouse model helps in search for better COPD and CF treatments

January 23, 2017
Researchers from Kumamoto University, Japan have succeeded in producing a mouse model that faithfully reproduces the pathologies of two intractable lung diseases, chronic obstructive pulmonary disease (COPD) and cystic fibrosis ...

New proteins to clear the airways in cystic fibrosis and COPD

July 13, 2012
University of North Carolina scientists have uncovered a new strategy that may one day help people with cystic fibrosis and chronic obstructive pulmonary disorder better clear the thick and sticky mucus that clogs their lungs ...

Repurposing heparin for inhalation may offer hope to millions with COPD

December 1, 2017
A drug used to thin blood has been found to also significantly improve the ability to breathe when inhaled by people with COPD (chronic obstructive pulmonary disease), for which there is no cure.

Scientists find gene linked to heightened mucus levels in lung disease

October 5, 2017
What if researchers could make breathing easier by changing how much mucus is in your lungs? Although healthy individuals have mucus in their lungs, mucus can be a major problem for people with chronic airway conditions, ...

Hope for chronic obstructive pulmonary disease

October 16, 2017
NUS pharmaceutical scientists have discovered that a naturally-derived compound is a potential drug candidate for chronic obstructive pulmonary disease (COPD).

Recommended for you

Dengue: Investigating antibodies to identify at-risk individuals

May 23, 2018
Using an original mathematical and statistical analysis method, a team of scientists from the Institut Pasteur partnered with researchers from the United States and Thailand to analyze a Thai cohort that has long been a focus ...

Fatty liver disease research set to benefit from stem cell advance

May 23, 2018
Scientists have developed a lab-based system for studying the most common type of liver disease, paving the way for research into new therapies.

More frequent checks control MRSA in newborns, but can hospitals afford them?

May 22, 2018
The more often a hospital can check its newborns for deadly MRSA germs, the more likely it will be that they are contained, according to a new study.

Could we predict the next Ebola outbreak by tracking the migratory patterns of bats?

May 22, 2018
Javier Buceta, associate professor of bioengineering, Paolo Bocchini, associate professor of civil and environmental engineering, and postdoctoral student Graziano Fiorillo of Lehigh University have created a modeling framework ...

Helping preterm infants grow bigger kidneys would prevent kidney disease later in life

May 21, 2018
Nephrons are the microscopic blood-filtering units inside our kidneys that convert waste products into urine, regulate our electrolyte levels and our blood pressure.

Kidney docs worry over no dialysis for undocumented immigrants

May 21, 2018
(HealthDay)—Undocumented immigrants in the United States are often denied treatment for kidney failure until they have a life-threatening emergency. Now a new study finds that the doctors and nurses who treat them are frustrated ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.